Evidence map›Paper›PMID 24886348›Full record

Trial reportTrials2014

Use acupuncture to relieve perimenopausal syndrome: study protocol of a randomized controlled trial.

Ying Li, Hui Zheng, Qianhua Zheng, Ling Zhao, Erqi Qin, Yu Wang, Qian Zeng, Huabin Zheng, Yu Zhao, Wei Sun and 3 more

Registry-linked trialOpen access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01933204 (Acupuncture for Relieving Perimenopausal Symptoms), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01933204 phase2 / phase3completednot on this map

Acupuncture for Relieving Perimenopausal Symptoms: a Randomised Controlled Trial

TypeinterventionalSponsorChengdu University of Traditional Chinese MedicineRan2013 to 2015Enrolled220ConditionsPerimenopauseArmsAcupuncture, Climen 21 Tablets
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Ying Li
Hui Zheng
Qianhua Zheng
Ling Zhao
Erqi Qin
Yu Wang
Qian Zeng
Huabin Zheng
Yu Zhao
Wei Sun
Xiaoxia Zhang
Zhishun Liu
Baoyan LiuGuang'anmen Hospital, China Academy of Chinese Medical Sciences, No, 5 BeiXianGe Street, XiCheng District, Beijing 100053, PR China. baoyanliutcm@sina.com.
Chengdu University of Traditional Chinese Medicine · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNIntegrated Chinese Medicine (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhether acupuncture is effective for relieving perimenopausal syndrome has been controversial recently. In this article, we report the protocol of a randomized controlled trial using acupuncture to treat perimenopausal syndrome, aiming to answer this controversy.

designA multicenter randomized controlled trial with two parallel arms is underway in China. Two hundred and six women with perimenopausal syndrome will be randomly assigned to a treatment group using acupuncture plus auricular acupressure (AA group) and a control group using Climen (Bayer Healthcare Company Limited, Guangzhou, China), a 28-day sequential hormone replacement therapy, in a 1:1 ratio. Participants in the AA group will receive three acupuncture sessions per week in the first 4 weeks and two sessions per week in the following 8 weeks, for a total of 28 sessions over 12 weeks. Auricular points will be plastered by Semen Vaccariae twice per week for a consecutive 12 weeks, with both ears used alternately. The Climen control group is prescribed a tablet containing estradiol valerate 2 mg/day for the first 11 days, and a tablet containing estradiol valerate 2 mg/day plus cyroterone acetate 1 mg/day for the following 10 days. The total treatment period of the control group is three cycles. The post-treatment follow-up period will last 24 weeks. The primary outcome is the Menopause Rating Scale (MRS) assessed at baseline and 4, 12, 16, 24 and 36 weeks after randomization. The secondary outcomes are Menopause-Specific Quality of Life, average hot flash score during 24 hours, serum estradiol, follicle-stimulating hormone and luteinizing hormone level. The first two secondary outcomes are measured at the same point as the MRS. Other secondary outcomes are measured at baseline and 12, 24 weeks after randomization. DISCUSSION: The results of this trial, which will be available in 2015, will clarify whether acupuncture is effective to relieve perimenopausal syndrome.

trial registrationClinicalTrials.gov NCT01933204 (registered 9 August 2013).

Indexed as

Acupuncture PointsPerimenopauseAcupressureAcupuncture, EarAdultEstradiolEstrogens, Conjugated (USP)FemaleHot FlashesHumansMiddle AgedQuality of LifeResearch DesignEstradiolEstrogens, Conjugated (USP)

Identifiers

PMID24886348
PMCPMC4055374
OpenAlexW2044851091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.